From: Mechanisms underlying linear ubiquitination and implications in tumorigenesis and drug discovery
Cancer type | Gene | Mechanism | Ref |
---|---|---|---|
Lymphoma | HOIP | Q584H and Q662L mutations of HOIP increase LUBAC activity and NF-κB signaling | [45] |
Lymphoma | CARD11 | Oncogenic CARD11 variants facilitate BCL10 linear ubiquitination by co-recruitment of HOIP and BCL10 | [71] |
Myeloid leukemia | HOIP | Knockdown of HOIP increases apoptosis in myeloid leukemia cells | [109] |
Breast cancer | Epsin1/2 | Heightened epsin levels promote NEMO linear ubiquitination, resulting in sustained NF-κB signaling | [110] |
Breast cancer | HOIP | HOIP facilitates p53 polyubiquitination and degradation by stabilizing MDM2 | [111] |
Breast cancer | SHARPIN | SHARPIN prolongs MDM2 protein stability to facilitate p53 degradation | [112] |
Breast cancer | SHARPIN | SHARPIN mediates monoubiquitination of ERα, blocking ERα polyubiquitination and protein degradation | [113] |
Breast cancer | HOIL-1 | HOIL-1 promots the transcription of ERα and cyclin B1 | [114] |
Breast cancer | HOIL-1 | HOIL-1 promotes YAP polyubiquitination and degradation | [115] |
Prostate cancer | PTEN | R173H and R173C mutations of PETN enhance the linear ubiquitination of PTEN, inhibiting PTEN phosphatase activity | [77] |
Ovarian cancer | HOIL-1 | HOIL-1 promotes PTEN polyubiquitination and degradation | [116] |
Renal cell carcinoma | HOIL-1 | HOIL-1 facilitates p53 proteolytic ubiquitination | [117] |
Renal cell carcinoma | SHARPIN | SHARPIN promotes the ubiquitination and proteasomal degradation of the tumor suppressor Von Hippel-Lindau | [118] |
Skin cancer | SHARPIN | SHARPIN promotes Rap1 expression | [119] |
Skin cancer | SHARPIN | SHARPIN enhances PRMT5 methyltransferase activity | [120] |
Liver cancer | HOIL-1 | HOIL-1 mediates the PPARγ/PGC1α complex ubiquitination and protein degradation | [121] |
Liver cancer | OTULIN | OTULIN inhibits FADD and RIPK1 kinase-mediated hepatocyte apoptosis | [122] |
Lung cancer | SHARPIN | SHARPIN interacts with PRMT5 to regulate histone H3R2 methylation-coupled transcriptional activation | [123] |
Lung cancer | HOIL-1 | HOIL-1 targets PKCζ for proteasomal degradation to promote tumor survival | [124] |
Glioblastoma | OTULIN | OTULIN removes linear ubiquitin conjugated on STAT3, leading to persistent STAT3 signaling | [79] |
Gastric cancer | SHARPIN | SHARPIN prevents β-catenin ubiquitination and proteasomal degradation | [125] |